PROPOFOL
NETs
Fudan UniversitySmall moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 81/ 100
Competitive context
12 Active assets in the NETs cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
DOTATOC ITM Solucin GmbH | Phase 2 | B |
ARG ITM Solucin GmbH | Phase 1 | CC |
LYSINE ITM Solucin GmbH | Phase 1 | CC |
Rocuronium Fudan University | N/A | D |
Oxycodone Fudan University | N/A | D |
View all 12 →
Same molecule, other indications
PROPOFOL is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →